• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群影响癌症治疗效果。

Gut Microbiota Shapes the Efficiency of Cancer Therapy.

作者信息

Ma Weidong, Mao Qixing, Xia Wenjie, Dong Gaochao, Yu Changhua, Jiang Feng

机构信息

Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.

The Fourth Clinical College of Nanjing Medical University, Nanjing, China.

出版信息

Front Microbiol. 2019 Jun 25;10:1050. doi: 10.3389/fmicb.2019.01050. eCollection 2019.

DOI:10.3389/fmicb.2019.01050
PMID:31293523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6604670/
Abstract

Systems biology provides an opportunity to discover the role that gut microbiota play in almost all aspects of human health. Existing evidence supports the hypothesis that gut microbiota is closely related to the pharmacological effects of chemical therapy and novel targeted immunotherapy. Gut microbiota shapes the efficiency of drugs through several key mechanisms: metabolism, immunomodulation, translocation, enzymatic degradation, reduction of diversity, and ecological variability. Therefore, gut microbiota have emerged as a novel target to enhance the efficacy and reduce the toxicity and adverse effects of cancer therapy. There is growing evidence to show that cancer therapy perturbs the host immune response and results in dysbiosis of the immune system, which then influences the efficiency of the therapy. Studies suggest that gut microbes play a significant role in cancer therapy by modulating drug efficacy, abolishing the anticancer effect, and mediating toxicity. In this review, we outline the role of gut microbiota in modulating cancer therapy and the implications for improving the efficacy of chemotherapy and immunotherapy in clinical practice. We also summarize the current limitations of the safety and effectiveness of probiotics in cancer therapies such as personalized cancer therapy.

摘要

系统生物学为发现肠道微生物群在人类健康几乎所有方面所起的作用提供了契机。现有证据支持肠道微生物群与化学疗法和新型靶向免疫疗法的药理作用密切相关这一假说。肠道微生物群通过几种关键机制塑造药物的疗效:代谢、免疫调节、易位、酶降解、多样性降低和生态变异性。因此,肠道微生物群已成为提高癌症治疗疗效、降低毒性和不良反应的新靶点。越来越多的证据表明,癌症治疗会扰乱宿主免疫反应并导致免疫系统失调,进而影响治疗效果。研究表明,肠道微生物通过调节药物疗效、消除抗癌作用和介导毒性在癌症治疗中发挥重要作用。在本综述中,我们概述了肠道微生物群在调节癌症治疗中的作用以及对提高临床化疗和免疫治疗疗效的意义。我们还总结了益生菌在个性化癌症治疗等癌症治疗中安全性和有效性方面目前存在的局限性。

相似文献

1
Gut Microbiota Shapes the Efficiency of Cancer Therapy.肠道微生物群影响癌症治疗效果。
Front Microbiol. 2019 Jun 25;10:1050. doi: 10.3389/fmicb.2019.01050. eCollection 2019.
2
Gut microbiota modulation of chemotherapy efficacy and toxicity.肠道微生物群调节化疗疗效和毒性。
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):356-365. doi: 10.1038/nrgastro.2017.20. Epub 2017 Mar 8.
3
Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.人类微生物群与个性化癌症治疗:共生微生物在癌症患者治疗结果中的作用
Cancer Treat Res. 2019;178:253-264. doi: 10.1007/978-3-030-16391-4_10.
4
Gut microbiota, an emergent target to shape the efficiency of cancer therapy.肠道微生物群,塑造癌症治疗疗效的一个新靶点。
Explor Target Antitumor Ther. 2023;4(2):240-265. doi: 10.37349/etat.2023.00132. Epub 2023 Apr 26.
5
Emerging role of microbiota in immunomodulation and cancer immunotherapy.微生物群在免疫调节和癌症免疫治疗中的新兴作用。
Semin Cancer Biol. 2021 May;70:37-52. doi: 10.1016/j.semcancer.2020.06.008. Epub 2020 Jun 21.
6
The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?肿瘤和肠道微生物组对癌症治疗的影响:有益还是有害?
Life Sci. 2019 Sep 15;233:116680. doi: 10.1016/j.lfs.2019.116680. Epub 2019 Jul 22.
7
The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy.肠道微生物群在肺癌中的作用:从致癌作用到免疫治疗
Front Oncol. 2021 Aug 19;11:720842. doi: 10.3389/fonc.2021.720842. eCollection 2021.
8
Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment.肠道微生物群、化疗与宿主:肠道微生物群对癌症治疗的影响
Ecancermedicalscience. 2018 Sep 5;12:868. doi: 10.3332/ecancer.2018.868. eCollection 2018.
9
Effects of microbiota on anticancer drugs: Current knowledge and potential applications.微生物群对抗癌药物的影响:现有知识和潜在应用。
EBioMedicine. 2022 Sep;83:104197. doi: 10.1016/j.ebiom.2022.104197. Epub 2022 Aug 4.
10
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?肠道微生物群:改善抗肿瘤治疗的新靶点?
Int J Mol Sci. 2019 Sep 17;20(18):4584. doi: 10.3390/ijms20184584.

引用本文的文献

1
Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers.植物化学物质作为女性癌症替代治疗策略的作用机制及益处
Chin Herb Med. 2025 Apr 11;17(3):448-463. doi: 10.1016/j.chmed.2025.04.002. eCollection 2025 Jul.
2
The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity.微生物代谢产物丁酸可增强小鼠CD8+T细胞的效应和记忆功能,并提高抗肿瘤活性。
Front Med (Lausanne). 2025 Jun 24;12:1577906. doi: 10.3389/fmed.2025.1577906. eCollection 2025.
3
Probiotics and Cancer: Mechanistic Insights and Organ-Specific Impact.

本文引用的文献

1
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
2
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.共生微生物群与转移性黑色素瘤患者的抗PD-1疗效相关。
Science. 2018 Jan 5;359(6371):104-108. doi: 10.1126/science.aao3290.
3
Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice.二甲双胍通过调节肠道微生物群改善肥胖老龄小鼠的代谢特征。
益生菌与癌症:机制洞察及器官特异性影响
Biomolecules. 2025 Jun 16;15(6):879. doi: 10.3390/biom15060879.
4
The Gut-Endometrium Axis: Exploring the Role of Microbiome in the Pathogenesis and Treatment of Endometrial Cancer-A Narrative Review.肠道-子宫内膜轴:探讨微生物群落在子宫内膜癌发病机制及治疗中的作用——一篇叙述性综述
Cancers (Basel). 2025 Mar 20;17(6):1044. doi: 10.3390/cancers17061044.
5
Exploring the Impact of Chemotherapy on the Emergence of Antibiotic Resistance in the Gut Microbiota of Colorectal Cancer Patients.探索化疗对结直肠癌患者肠道微生物群中抗生素耐药性出现的影响。
Antibiotics (Basel). 2025 Mar 5;14(3):264. doi: 10.3390/antibiotics14030264.
6
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome.在学术癌症中心网络中实施团队科学以揭示肠道微生物组的结构与功能。
J Clin Med. 2025 Mar 17;14(6):2040. doi: 10.3390/jcm14062040.
7
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans.人类结直肠癌肠道微生物群相关治疗策略的进展
Cancer Biol Med. 2025 Mar 12;22(2):93-112. doi: 10.20892/j.issn.2095-3941.2024.0263.
8
Impact of cigarette smoking on gut microbial dysbiosis: a structured literature review.吸烟对肠道微生物失调的影响:一项结构化文献综述
Gut Microbiome (Camb). 2024 May 2;5:e13. doi: 10.1017/gmb.2024.3. eCollection 2024.
9
Precision models in hepatocellular carcinoma.肝细胞癌中的精准模型
Nat Rev Gastroenterol Hepatol. 2025 Mar;22(3):191-205. doi: 10.1038/s41575-024-01024-w. Epub 2024 Dec 11.
10
Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota.肠道微生物群对胶质母细胞瘤免疫环境的调节作用
Biomedicines. 2024 Oct 23;12(11):2429. doi: 10.3390/biomedicines12112429.
Gut Microbes. 2018 Mar 4;9(2):155-165. doi: 10.1080/19490976.2017.1405209. Epub 2018 Feb 13.
4
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.肠道微生物组影响基于 PD-1 的免疫疗法对上皮性肿瘤的疗效。
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
5
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.肠道微生物群调节黑色素瘤患者对抗PD-1免疫疗法的反应。
Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.
6
The role of the microbiome in cancer development and therapy.微生物群落在癌症发展和治疗中的作用。
CA Cancer J Clin. 2017 Jul 8;67(4):326-344. doi: 10.3322/caac.21398. Epub 2017 May 8.
7
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota.通过调控肠道微生物群增强免疫检查点阻断疗法的临床覆盖范围和抗癌疗效。
Oncoimmunology. 2016 Feb 18;6(1):e1132137. doi: 10.1080/2162402X.2015.1132137. eCollection 2017.
8
Microbes and Cancer.微生物与癌症。
Annu Rev Immunol. 2017 Apr 26;35:199-228. doi: 10.1146/annurev-immunol-051116-052133. Epub 2017 Jan 30.
9
Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.免疫检查点抑制剂的胃肠道和肝脏并发症
Curr Gastroenterol Rep. 2017 Jan;19(1):3. doi: 10.1007/s11894-017-0540-6.
10
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.屎肠球菌和人肠球菌有助于环磷酰胺诱导的治疗性免疫调节作用。
Immunity. 2016 Oct 18;45(4):931-943. doi: 10.1016/j.immuni.2016.09.009. Epub 2016 Oct 4.